Odyssey Health, Inc. (ODYY)
Odyssey Health, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $1.0M. On trailing twelve-month figures it carries a trailing P/E of -0.30, a net margin of 0.0%. Its beta of -1.39 implies it has historically moved less than the broad market.
Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products. Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screening, alongside the "Save A Life" line of devices engineered for choking emergencies. Additionally, the company is advancing neurosteroid drug compounds, PRV-001 and PRV-002, intended for the treatment of concussive injuries and various rare brain disorders. The organization, established in 2014 and headquartered in Las Vegas, Nevada, was previously known as Odyssey Group International, Inc.
Odyssey Health, Inc. is most often compared with the following Healthcare names: